Form D Explorer

Inspect source fieldsReport a record issue

Form D — Lighthouse Pharmaceuticals, Inc.

0002133359-26-000001 · filed May 7, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other filings

Offering

Industry
Other
Exemptions
Rule 506(b)
Reported offering amount
$15,206,800
Reported amount sold
$15,206,800
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Lighthouse Pharmaceuticals, Inc.
CIK
2133359
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
8001 REDWOOD BLVD
NOVATO, California 94945
Phone
650 488 8430

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗